How PKC Affects Telomerase in Head and Neck Cancer
Author Information
Author(s): Chang J T, Lu Y-C, Chen Y-J, Tseng C-P, Chen Y-L, Fang C-W, Cheng A-J
Primary Institution: Chang Gung Memorial Hospital
Hypothesis
Does protein kinase C (PKC) regulate telomerase activity in head and neck cancer cells?
Conclusion
PKC isoenzymes α, β, δ, ɛ, and ζ regulate telomerase activity in head and neck cancer cells by phosphorylating hTERT.
Supporting Evidence
- PKC inhibitors reduced telomerase activity in cancer cells.
- PKC isoforms α, β, δ, ɛ, and ζ were found to be involved in telomerase regulation.
- Phosphorylation of hTERT by PKC is essential for telomerase activity.
- Disruption of PKC phosphorylation increased chemosensitivity to cisplatin.
Takeaway
This study found that a protein called PKC helps another protein, hTERT, work properly in cancer cells, which is important for the cancer to grow.
Methodology
The study used cell lines and tissue samples to examine the effects of PKC inhibitors and activators on telomerase activity and protein interactions.
Potential Biases
Potential bias in the selection of tissue samples and the specific cell line used.
Limitations
The study was limited to a small sample size of tumor tissues and may not represent all head and neck cancers.
Participant Demographics
Patients with head and neck squamous cell carcinoma.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website